| abstract |
Disclosed is a peptide having the ability to induce cytotoxic T cells. Based on the identification of specific epitope peptides of the gene products of these genes (MPHOSPH1 and DEPDC1) that have the ability to induce cytotoxic T lymphocytes (CTLs) specific for the corresponding molecules. In addition to a peptide having a specific amino acid sequence, a peptide in which 1, 2 or several amino acids of the peptide having the amino acid sequence are substituted, deleted, or added. The present invention is also used as a medicament or vaccine for the treatment or prevention of diseases (eg, cancer) associated with overexpression of MPHOSPH1 and / or DEPDC1 comprising these peptides as active ingredients. [Selection figure] None |